Paul Oestreicher is an accomplished strategic PR/PA practitioner, team and business builder, leader, adviser, educator and author. Paul has an extensive track record of providing senior-level counsel, and positioning companies and products, and is a recognized leader in issues and crisis management. Paul is one of the early architects of direct-to-patient communications and third-party alliance building.
Paul started at Hoffmann-La Roche as a clinical project coordinator in the Clinical Research and Development department working in a variety of areas including inflammation, gastrointestinal diseases and obesity. Gravitating toward the “business of science,” he had roles of increasing responsibility in their Public Policy and Communications Department, and acted as a company spokesperson on R&D, HIV/AIDS and oncology. As Vice President of Strategic Marketing and Communications at Genaissance Pharmaceuticals, Paul led corporate communications, investor relations (including the Company’s IPO and annual reports), government relations, internal communications, new business support and the web site. In addition, he organized the first continuing medical education (CME) programs on pharmacogenetics with the American Medical Association and Yale University, and the industry’s first workshop on the subject with the FDA. Other positions held were Vice President of Communications for North America at Sanofi-Synthelabo Inc., General Manager at Edelman Health and US Healthcare Practice Director at Hill & Knowlton.
He is also an Adjunct Professor at New York University’s M.S. program in Corporate Communications and Public Relations, where he teaches Research Process & Methodology, Strategic Communication, and Communication Ethics, Law & Regulation. Paul also advises students on their thesis projects and is developing an annual Reputation Management Best Practices survey. He was honored with NYU's Award for Teaching Excellence in 2012.
Paul has published on marketing and communications issues in PRWeek, Scrip Magazine, Nature Biotechnology, Medical Marketing & Media, and Tactics, and writes his blog, C-O-I-N-S: Communication Opinions, Insights and New Strategies. His book, Camelot, Inc.: Leadership and Management Insights from King Arthur and the Round Table, uses passages from Arthurian legends to illustrate the dos and don’ts of modern leaders and institutions.
Paul earned a bachelor’s degree in biology from the University of Rochester, an M.S. and Ph.D. in nutritional sciences from Rutgers University, and completed a post-doctoral fellowship in pharmacology while with Wyeth Laboratories. He has served on a number of committees and organizations, including the Healthcare Communication & Marketing Association (HCMA), the Biotechnology Industry Organization (BIO), the Pharmaceutical Research and Manufacturers Association (PhRMA), the Keystone Center for Science & Public Policy, Connecticut United for Research Excellence (CURE), The Gene Media Forum, and the National Cancer Institute’s Cancer Communications Task Force. He is currently president of the Southern Connecticut Science & Engineering Foundation. And, Paul holds five toy patents. TagsMania markets his award-winning, engaging toys for babies and toddlers.